UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of the fallopian tube in the origin of ovarian cancer

American journal of obstetrics and gynecology, 2013-11, Vol.209 (5), p.409-414

2013

Volltextzugriff (PDF)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

International journal of molecular sciences, 2019-01, Vol.20 (1), p.229

2019

Volltextzugriff (PDF)

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

Journal of clinical oncology, 2008-02, Vol.26 (6), p.995-1005

2008

Volltextzugriff (PDF)

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

International journal of molecular sciences, 2017-10, Vol.18 (10), p.2171

2017

Volltextzugriff (PDF)

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (15), p.6910-6918

2005

Volltextzugriff (PDF)

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer

International Journal of Molecular Sciences, 2013-04, Vol.14 (4), p.8213-8227

2013

Volltextzugriff (PDF)

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Clinical cancer research, 2012-02, Vol.18 (3), p.869-881

2012

Volltextzugriff (PDF)

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

Molecular cancer therapeutics, 2010-12, Vol.9 (12), p.3186-3199

2010

Volltextzugriff (PDF)

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Clinical cancer research, 2006-08, Vol.12 (16), p.4916-4924

2006

Volltextzugriff (PDF)

The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3978-3988

2016

Volltextzugriff (PDF)

Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer

Clinical cancer research, 2007-12, Vol.13 (24), p.7487-7495

2007

Volltextzugriff (PDF)

Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation

Experimental cell research, 2013-03, Vol.319 (5), p.697-706

2013

Volltextzugriff (PDF)

The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Clinical cancer research, 2006-03, Vol.12 (6), p.1707-1714

2006

Volltextzugriff (PDF)

Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer

Cancer research (Chicago, Ill.), 2019-09, Vol.79 (18), p.4599-4611

2019

Volltextzugriff (PDF)

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Molecular cancer research, 2018-05, Vol.16 (5), p.813-824

2018

Volltextzugriff (PDF)

Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10389-10396

2007

Volltextzugriff (PDF)

Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer

Clinical cancer research, 2017-11, Vol.23 (21), p.6529-6540

2017

Volltextzugriff (PDF)

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

Oncotarget, 2014-09, Vol.5 (18), p.8750-8764

2014

Volltextzugriff (PDF)

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Nature medicine, 2006-08, Vol.12 (8), p.939-944

2006

Volltextzugriff (PDF)

Stress Hormone–Mediated Invasion of Ovarian Cancer Cells

Clinical cancer research, 2006-01, Vol.12 (2), p.369-375

2006

Volltextzugriff (PDF)

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

Cancer research (Chicago, Ill.), 2007, Vol.67 (1), p.281-288

2007

Volltextzugriff (PDF)

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors

Cell reports (Cambridge), 2021-11, Vol.37 (5), p.109953-109953, Article 109953

2021

Volltextzugriff (PDF)

Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer

Clinical cancer research, 2011-09, Vol.17 (17), p.5674-5685

2011

Volltextzugriff (PDF)

Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study

Gynecologic oncology, 2020-03, Vol.156 (3), p.636-640

2020

Volltextzugriff (PDF)

ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells

Journal of ovarian research, 2013-04, Vol.6 (1), p.25-25, Article 25

2013

Volltextzugriff (PDF)

1 – 25 von 142

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(132)
Mit Volltextzugriff
(131)

Publikationsform

Artikel
(141)
Berichte
(1)

Sprache

Englisch
(142)
Japanisch
(31)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The role of the fallopian tube in the origin of ovarian cancer

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer

Early Events in the Pathogenesis of Epithelial Ovarian Cancer

Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype

Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer

Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation

The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Chemotherapy-Induced Distal Enhancers Drive Transcriptional Programs to Maintain the Chemoresistant State in Ovarian Cancer

Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

Neuroendocrine Modulation of Signal Transducer and Activator of Transcription-3 in Ovarian Cancer

Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer

Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer

Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma

Stress Hormone–Mediated Invasion of Ovarian Cancer Cells

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

A patch of positively charged residues regulates the efficacy of clinical DR5 antibodies in solid tumors

Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer

Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study

ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells

Suchergebnisse filtern